FIELD: pharmaceutics.
SUBSTANCE: present invention relates to a compound represented by the formula I:
or its pharmaceutically acceptable salt, where R1 is represented by the formula:
,
where is a monocyclic C6 aryl or 5-7-element heteroaryl group containing 1-2 heteroatoms selected from N, O or S; each A is independently optionally fluorinated C1-8 alkyl, optionally fluorinated C1-8 alkoxy, optionally fluorinated C3-8 cycloalkyl, -CF3 or halogen; n is 1 or 2; where the first substituent A is located ortho to an attachment point from depicted pyrazole ring; R2 is C3-8 alkyl, C1-8 alkyl-C3-8 cycloalkyl, C3-8 cycloalkyl or C6-10 aryl, substituted C1-8 alkyl; R4 is optionally fluorinated C1-8 alkyl, C1-8 alkyl-C6 aryl, C1-8 alkyl-C3-8 cycloalkyl, C1-8 alkyl-5-14-element heteroaryl, where heteroaryl contains from 1 to 4 heteroatoms selected from N, O or S, or (CH2)xNR7R8; R5 is optionally substituted C1-8 alkyl, C1-8 alkylamino, C1-8 alkylamido, C2-8 alkyl-C6 aryl, C1-8 alkyl-C3-8 cycloalkyl, C1-8 alkyl-5-14-element heteroaryl, where heteroaryl contains from 1 to 4 heteroatoms selected from N, O or S, C1-8 alkyltetrazole-5-one, (CH2)xNR7R8, (CH2)xOR7, (CH2)xCONR7R8, (CH2)xCOR7, (CH2)xxCO2R7; R6 is H or each of R7 and R8 is independently H, C1-8 alkyl-5-14-element heteroaryl, C3-8 cycloalkyl, -(CH2)xCO2R9 or 5-17-element heteroaryl, where heteroaryl contains from 1 to 4 heteroatoms selected from N, O, S; or R7 and R8 together form 3-9-element ring that can contain one or two heteroatoms selected from N or O; or R9 is H or C1-8 alkyl; each x is independently equal to 0, 1, 2, 3, 4, 5, 6, 7 or 8; and each xx is independently equal to 0, 1, 2, 3, 4, 5, 6, 7 or 8. Pharmaceutical compositions and applications for the treatment of disorders related to an apelin receptor (APJ) are also proposed.
EFFECT: technical result consists in obtaining new organic compounds that are agonists of the apelin receptor (APJ) and that can be used to reduce blood pressure.
23 cl, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
APELIN RECEPTOR AGONISTS (APJ) AND USE THEREOF | 2015 |
|
RU2705800C2 |
N-((HET)ARYLMETHYL)-HETEROARYL-CARBOXAMIDE COMPOUNDS AS PLASMA KALLIKREIN INHIBITORS | 2015 |
|
RU2821520C2 |
GEMINALLY SUBSTITUTED CYANOETHYLPYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2664533C2 |
N-((HET)ARYLMETHYL)-HETEROARYL-CARBOXAMIDE COMPOUNDS AS PLASMA KALLIKREIN INHIBITORS | 2015 |
|
RU2707870C2 |
PYRAZOLOPYRIDINE DERIVATIVES AS KINASE INHIBITORS | 2015 |
|
RU2733400C2 |
SUBSTITUTED HETEROCYCLIC SULPHONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS | 2014 |
|
RU2675792C2 |
DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE | 2014 |
|
RU2662832C2 |
PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA | 2013 |
|
RU2658006C2 |
BICYCLIC LACTAMS AND METHODS FOR USE THEREOF | 2016 |
|
RU2716136C2 |
SULTAM-BASED COMPOUND AND METHOD OF USE THEREOF | 2017 |
|
RU2741915C2 |
Authors
Dates
2022-02-08—Published
2016-12-09—Filed